TS
IMGO

Thomas Steyer’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Thomas Steyer’s Portfolio IMGO Stock Details IMGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,471,313
Closed -$37.2M – 265
2022
Q3 		$37.2M Hold
2,471,313
– – 0.2% 79
2022
Q2 		$33.1M Hold
2,471,313
– – 0.18% 79
2022
Q1 		$47.6M Hold
2,471,313
– – 0.23% 70
2021
Q4 		$58.6M Sell
2,471,313
-200,000
-7% -$4.63M 0.29% 61
2021
Q3 		$53.5M Buy
+2,671,313
New +$57.3M 0.25% 72

Other funds holding IMGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Thomas Steyer's IMGO Position: Q4 2022 in Review

Thomas Steyer sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q4 2022, closing a stake of 2,471,313 shares — an estimated $37.2M sold.

Thomas Steyer first reported a position in IMGO in Q3 2021 and held it in 5 quarters. The position peaked at $58.6M in Q4 2021. 106 funds tracked by Wall St. Rank hold IMGO as of Q4 2022.

  • Thomas Steyer reported no remaining Imago BioSciences, Inc. Common stock position as of Q4 2022 after selling out during the quarter.
  • Thomas Steyer sold 2,471,313 Imago BioSciences, Inc. Common stock shares in Q4 2022, an estimated $37.2M.
  • Thomas Steyer first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 5 quarters.
  • Thomas Steyer's Imago BioSciences, Inc. Common stock position peaked at $58.6M in Q4 2021.
  • 106 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q4 2022.

Based on Farallon Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.